CoChat

Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016

Open access
Mehta, Paul, Raymond, Jaime, Punjani, Reshma, Larson, Theodore, Bove, Frank, Kaye, Wendy, Nelson, Lorene M., Topol, Barbara, Han, Moon, Muravov, Oleg, Genson, Corina, Davis, Bryn, Hicks, Thomas, Horton, Kevin · 2022 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Objective: To estimate the prevalence of amyotrophic lateral sclerosis (ALS) in the United States for 2016 using data from the National ALS Registry (Registry). Established in 2009, the Registry collects data on ALS patients in the U.S. to better describe the epidemiology of ALS, examine risk factors such as environmental and occupational exposures, and characterize the demographics of those living with the disease. Methods: To identify adult prevalent cases of ALS, the Registry compiles data from three national administrative databases (maintained by the Centers for Medicare and Medicaid Services, the Veterans Health Administration, and the Veterans Benefits Administration). To ascertain cases not necessarily included in these databases and to better understand risk-factors associated with ALS and disease progression, the Registry also includes data collected from patients who voluntarily enroll via a web portal to complete online surveys. Results: In 2016, the Registry conservatively identified 16,424 adult persons who met the Registry definition of ALS for an age-adjusted prevalence rate of 5.2 per 100,000 U.S. population. The pattern of patient characteristics (e.g., age, sex, and race/ethnicity) has not changed from previous Registry reports. Overall, ALS was more common among whites, males, and persons aged 60–69 years. The age groups with the lowest number of ALS cases were persons aged 18–39 years. Males had a higher prevalence rate of ALS than females overall and across all data sources. Conclusions: Data collected by the National ALS Registry are being used to better describe the epidemiology and demographics of ALS in the U.S.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/21678421.2021.1949021

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Research works printed but not linked: 6

  1. US Public Health Service, 2008, ALS Registry Act
  2. Mehta P, 2014, MMWR Suppl, 63, 1
  3. Klein RJ, 2001, Healthy People 2010 Stat Notes., 1
  4. Keyfitz N., 1966, Hum Biol, 38, 309
  5. Huber S, 1995, Schweiz Arch Neurol Psychiatr (1985), 146, 52
  6. US Census Bureau, 2014, Total population 2014 American community survey 1-year

Cited by

See all 89

Metadata

Authors
Mehta, P., Raymond, J., Punjani, R., Larson, T., Bove, F., Kaye, W., Nelson, L. M., Topol, B., Han, M., Muravov, O., Genson, C., Davis, B., Hicks, T., & Horton, K.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USA
  • McKing Consulting (United States) (US)
  • Stanford Medicine (US)
  • Carter Consulting, Inc, Atlanta, GA, USA
Corresponding author
Mehta, Paul
Venue
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Published
2021-08-23
Volume
23
Issue
3-4
Pages
220-225
ISSN
  • 2167-8421 (ISSN-L)
  • 2167-9223
OpenAlex
W3194791349
Cited by
84
References
53
Citations by year
2026: 6 · 2025: 5 · 2024: 9 · 2023: 12 · 2022: 10 · 2021: 14
FWCI
5.38
Type
journal article
Language
en
Open access
Locations
  • Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (publishedVersion, public-domain)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
  • Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
Keywords
amyotrophic lateral sclerosis, prevalence, National ALS Registry, sex differences, age distribution, racial and ethnic differences, risk factors, disease progression, United States
MeSH terms
Adult, Aged, Amyotrophic Lateral Sclerosis, Female, Medicare, Humans, Male, Registries, United States, Prevalence, Databases, Factual

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016. https://app.cochat.ai/papers/10.1080/21678421.2021.1949021
The paper
Mehta, P., Raymond, J., Punjani, R., Larson, T., Bove, F., Kaye, W., Nelson, L. M., Topol, B., Han, M., Muravov, O., Genson, C., Davis, B., Hicks, T., & Horton, K. (2022). Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. https://doi.org/10.1080/21678421.2021.1949021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.